Authors

  • Shirinova Zuhra Tayirovna
    Termiz University of Economics and Service

DOI:

https://doi.org/10.71337/inlibrary.uz.mpttp.64506

Keywords:

pelvis epidemiology prevention diagnosis inflammation labia

Abstract

This article reviews the history of pelvic inflammatory disease and provides information on how to prevent its spread. Epidemiological features of the disease, spreading factors and diagnostic methods were analyzed in the study. The main focus is on effective disease prevention measures, including vaccination, sanitation and public education. This article describes strategies to prevent pelvic inflammatory disease.


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

488

https://universalpublishings.com

MODERN PREVENTION OF PELVIC INFLAMMATORY DISEASES

Shirinova Zuhra Tayirovna

Termiz University of Economics and Service

Email -

Zuhrashirinova5@gmail.com


Abstract:

This article reviews the history of pelvic inflammatory disease and

provides information on how to prevent its spread. Epidemiological features of the
disease, spreading factors and diagnostic methods were analyzed in the study. The main
focus is on effective disease prevention measures, including vaccination, sanitation and
public education. This article describes strategies to prevent pelvic inflammatory
disease.


Key words:

pelvis, epidemiology, prevention, diagnosis, inflammation, labia.


Pelvic

inflammatory

disease

,

also

known

as

pelvic

inflammatory

disorder

(

PID

), is an infection of the upper part of the female reproductive system,

mainly the uterus, fallopian tubes, and ovaries, and inside of the pelvis. Often, there
may be no symptoms. Signs and symptoms, when present, may include lower
abdominal pain, vaginal discharge, fever, burning with urination, pain with
sex,
bleeding after sex, or irregular menstruation. Untreated PID can result in long-
term complications including infertility, ectopic pregnancy, chronic pelvic pain,
and cancer.

The disease is caused by bacteria that spread from the vagina and cervix. It has been

reported that infections by

Neisseria gonorrhoeae

or

Chlamydia trachomatis

are

present in 75 to 90 percent of cases. However, in the UK it is reported by the NHS that
infections by

Neisseria gonorrhoeae

and

Chlamydia trachomatis

are responsible for

only a quarter of PID cases. Often, multiple different bacteria are involved.

Without treatment, about 10 percent of those with a chlamydial infection and 40

percent of those with a gonorrhea infection will develop PID. Risk factors are generally
similar to those of sexually transmitted infections and include a high number of sexual
partners
and drug use. Vaginal douching may also increase the risk. The diagnosis is
typically based on the presenting signs and symptoms. It is recommended that the
disease be considered in all women of childbearing age who have lower abdominal


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

489

https://universalpublishings.com

pain. A definitive diagnosis of PID is made by finding pus involving the fallopian tubes
during surgery. Ultrasound may also be useful in diagnosis.

Efforts to prevent the disease include not having sex or having few sexual partners

and using condoms. Screening women at risk for chlamydial infection followed by
treatment decreases the risk of PID. If the diagnosis is suspected, treatment is typically
advised. Treating a woman's sexual partners should also occur. In those with mild or
moderate symptoms, a single injection of the antibiotic ceftriaxone along with two
weeks of doxycycline and possibly metronidazole by mouth is recommended. For
those who do not improve after three days or who have severe disease, intravenous
antibiotics should be used.

Globally, about 106 million cases of chlamydia and 106 million cases of gonorrhea

occurred in 2008. The number of cases of PID, however, is not clear. It is estimated to
affect about 1.5 percent of young women yearly. In the United States, PID is estimated
to affect about one million people each year. A type of intrauterine device (IUD)
known as the Dalkon shield led to increased rates of PID in the 1970s. Current IUDs
are not associated with this problem after the first month.

Signs and symptoms






Illustration of pelvic inflammatory disease
Symptoms

in

PID

range

from

none

to

severe.

If

there

are

symptoms, fever, cervical motion tenderness, lower abdominal pain, new or different
discharge, painful intercourse, uterine tenderness, adnexal tenderness, or irregular
menstruation may be noted.

Other

complications

include endometritis, salpingitis, tubo-ovarian

abscess,

pelvic peritonitis, periappendicitis, and perihepatitis.


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

490

https://universalpublishings.com

Complications

Fitz-Hugh–Curtis syndrome with perihepatic adhesions following a chlamydia

infection

PID can cause scarring inside the reproductive system, which can later cause serious

complications, including chronic pelvic pain, infertility, ectopic pregnancy (the leading
cause of pregnancy-related deaths in adult females), and other complications of
pregnancy. Occasionally, the infection can spread to the peritoneum causing
inflammation and the formation of scar tissue on the external surface of the liver (Fitz-
Hugh–Curtis syndrome).

Cause
Chlamydia trachomatis

and

Neisseria gonorrhoeae

are common causes of PID.

However, PID can also be caused by other untreated infections, like bacterial vaginosis.
Data suggest that PID is often polymicrobial. Isolated anaerobes and facultative
microorganisms
have been obtained from the upper genital tract.

N. gonorrhoeae

has

been isolated from fallopian tubes, facultative and anaerobic organisms were recovered
from endometrial tissues.

The anatomical structure of the internal organs and tissues of the female

reproductive tract provides a pathway for pathogens to ascend from the vagina to the
pelvic cavity through the infundibulum. The disturbance of the naturally occurring
vaginal microbiota associated with bacterial vaginosis increases the risk of PID.

N. gonorrhoea

and

C. trachomati

s are the most common organisms. The least

common were infections caused exclusively by anaerobes and facultative organisms.
Anaerobes and facultative bacteria were also isolated from 50 percent of the patients
from whom

Chlamydia

and

Neisseria

were recovered; thus, anaerobes and facultative

bacteria were present in the upper genital tract of nearly two-thirds of the PID
patients. PCR and serological tests have associated extremely fastidious organism with


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

491

https://universalpublishings.com

endometritis, PID, and tubal factor infertility. Microorganisms associated with PID are
listed below.

Cases of PID have developed in people who have stated they have never had sex.

Bacteria

Chlamydia trachomatis

Neisseria gonorrhoeae

Prevotella

spp.

Streptococcus pyogenes

Prevotella bivia

Prevotella disiens

Bacteroides

spp.

Peptostreptococcus asaccharolyticus

Peptostreptococcus anaerobius

Gardnerella vaginalis

Escherichia coli

Group B streptococcus

α-hemolytic streptococcus

Coagulase-negative staphylococcus

Atopobium vaginae

Acinetobacter

spp.

Dialister

spp.

Fusobacterium gonidiaformans

Gemella

spp.

Leptotrichia

spp.

Mogibacterium

spp.

Porphyromonas

spp.

Sphingomonas

spp.

Veillonella

spp.

Cutibacterium acnes

Mycoplasma genitalium

Mycoplasma hominis

Ureaplasma

spp.


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

492

https://universalpublishings.com

Diagnosis

Mucopurulent cervical discharge seen on a cotton bud

Micrograph of salpingitis – a component of pelvic inflammatory disease. H&E

stain.

Upon a pelvic examination, cervical motion, uterine, or adnexal tenderness will be

experienced.

[5]

Mucopurulent cervicitis and or urethritis may be observed. In severe

cases more testing may be required such as laparoscopy, intra-abdominal bacteria
sampling and culturing, or tissue biopsy.

Laparoscopy can visualize "violin-string" adhesions, characteristic of Fitz-Hugh–

Curtis perihepatitis and other abscesses that may be present.

Other imaging methods, such as ultrasonography, computed tomography (CT), and

magnetic imaging (MRI), can aid in diagnosis. Blood tests can also help identify the
presence of infection: the erythrocyte sedimentation rate (ESR), the C-reactive protein
(CRP) level, and chlamydial and gonococcal DNA probes.

Nucleic acid amplification tests (NAATs), direct fluorescein tests (DFA), and

enzyme-linked immunosorbent assays (ELISA) are highly sensitive tests that can
identify specific pathogens present. Serology testing for antibodies is not as useful


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

493

https://universalpublishings.com

since the presence of the microorganisms in healthy people can confound interpreting
the antidiv titer levels, although antidiv levels can indicate whether an infection is
recent or long-term.

Definitive criteria include histopathologic evidence of endometritis, thickened

filled fallopian tubes, or laparoscopic findings. Gram stain/smear becomes definitive
in the identification of rare, atypical and possibly more serious organisms. Two thirds
of patients with laparoscopic evidence of previous PID were not aware they had PID,
but even asymptomatic PID can cause serious harm.

Laparoscopic identification is helpful in diagnosing tubal disease; a 65 percent to

90 percent positive predictive value exists in patients with presumed PID.

Upon gynecologic ultrasound, a potential finding is

tubo-ovarian complex

, which

is edematous and dilated pelvic structures as evidenced by vague margins, but
without abscess formation.

Differential diagnosis

A number of other causes may produce similar symptoms including appendicitis,

ectopic pregnancy, hemorrhagic or ruptured ovarian cysts, ovarian torsion, and
endometriosis and gastroenteritis, peritonitis, and bacterial vaginosis among others.

Pelvic inflammatory disease is more likely to reoccur when there is a prior history

of the infection, recent sexual contact, recent onset of menses, or an IUD (intrauterine
device) in place or if the partner has a sexually transmitted infection.

Acute pelvic inflammatory disease is highly unlikely when recent intercourse has

not taken place or an IUD is not being used. A sensitive serum pregnancy test is
typically

obtained

to

rule

out

ectopic

pregnancy. Culdocentesis will

differentiate hemoperitoneum (ruptured ectopic pregnancy or hemorrhagic cyst) from
pelvic sepsis (salpingitis, ruptured pelvic abscess, or ruptured appendix).

Pelvic and vaginal ultrasounds are helpful in the diagnosis of PID. In the early stages

of infection, the ultrasound may appear normal. As the disease progresses, nonspecific
findings can include free pelvic fluid, endometrial thickening, uterine cavity distension
by fluid or gas. In some instances the borders of the uterus and ovaries appear indistinct.
Enlarged ovaries accompanied by increased numbers of small cysts correlates with
PID.

Laparoscopy is infrequently used to diagnose pelvic inflammatory disease since it

is not readily available. Moreover, it might not detect subtle inflammation of the
fallopian tubes, and it fails to detect endometritis. Nevertheless, laparoscopy is


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

494

https://universalpublishings.com

conducted if the diagnosis is not certain or if the person has not responded to antibiotic
therapy after 48 hours.

No single test has adequate sensitivity and specificity to diagnose pelvic

inflammatory disease. A large multisite U.S. study found that cervical motion
tenderness as a minimum clinical criterion increases the sensitivity of
the CDC diagnostic criteria from 83 percent to 95 percent. However, even the modified
2002 CDC criteria do not identify women with subclinical disease.

Prevention

Regular

testing

for sexually

transmitted

infections is

encouraged

for

prevention. The risk of contracting pelvic inflammatory disease can be reduced by the
following:

Using barrier methods such as condoms; see human sexual behaviour for other
listings.

[32]

Using latex condoms to prevent STIs that may go untreated.

Seeking medical attention if you are experiencing symptoms of PID.

Using hormonal combined contraceptive pills also helps in reducing the chances of
PID by thickening the cervical mucosal plug & hence preventing the ascent of
causative organisms from the lower genital tract

Seeking medical attention after learning that a current or former sex partner has, or
might have had a sexually transmitted infection.

Getting a STI history from your current partner and strongly encouraging they be tested
and treated before intercourse.

Diligence in avoiding vaginal activity, particularly intercourse, after the end of a
pregnancy (delivery, miscarriage, or abortion) or certain gynecological procedures, to
ensure that the cervix closes.

Reducing the number of sexual partners; As in sexual monogamy.

Treatment

Treatment is often started without confirmation of infection because of the serious

complications that may result from delayed treatment. Treatment depends on
the infectious agent and generally involves the use of antibiotic therapy although there
is no clear evidence of which antibiotic regimen is more effective and safe in the
management of PID. If there is no improvement within two to three days, the patient is
typically advised to seek further medical attention. Hospitalization sometimes becomes
necessary if there are other complications. Treating sexual partners for possible STIs
can help in treatment and prevention. There should be no wait for STI results to start


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

495

https://universalpublishings.com

treatment. Treatment should not be avoided for longer than 2-3 days due to increasing
the risk of infertility.

For women with PID of mild to moderate severity, parenteral and oral therapies

appear to be effective. It does not matter to their short- or long-term outcome whether
antibiotics are administered to them as inpatients or outpatients. Typical regimens
include cefoxitin or cefotetan plus doxycycline, and clindamycin plus gentamicin. An
alternative

parenteral

regimen

is ampicillin/sulbactam plus

doxycycline. Erythromycin-based medications can also be used. A single study
suggests superiority of azithromycin over doxycycline. Another alternative is to use a
parenteral regimen with ceftriaxone or cefoxitin plus doxycycline. Clinical experience
guides decisions regarding transition from parenteral to oral therapy, which usually can
be initiated within 24–48 hours of clinical improvement.

When PID is caught early there are treatments that can be utilized, however these
treatments will not undo any damage PID may has caused.

If previously having a PID diagnosis and were to be exposed to another STI the risk of
having PID reoccur is higher

Early treatment can not prevent the following:

chronic abdominal pain.

infertility and or ectopic pregnancies.

scar tissue within or outside the fallopian tubes.

Prognosis

Early diagnosis and immediate treatment are vital in reducing the chances of later

complications from PID. Delaying treatment for even a few days could greatly increase
the chances of further complications. Even when the PID infection is cured, effects of
the infection may be permanent, or long lasting. This makes early identification
essential.

A limitation of this is that diagnostic tests are not included in routine check-ups, and

cannot be done using signs and symptoms alone; the required diagnostic tests are more
invasive than that. Treatment resulting in cure is very important in the prevention of
damage to the reproductive system. Around 20 percent of women with PID develop
infertility. Even women who do not experience intense symptoms or are asymptomatic
can become infertile. This can be caused by the formation of scar tissue due to one or
more episodes of PID, and can lead to tubal blockage. Both of these increase the risk
of the inability to get pregnant, and 1% results in an ectopic pregnancy.

[40]

Chronic


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

496

https://universalpublishings.com

pelvic/abdominal pain develops post PID 40% of the time.

[40]

Certain occurrences such

as a post pelvic operation, the period of time immediately after childbirth
(postpartum), miscarriage or abortion increase the risk of acquiring another infection
leading to PID.

Epidemiology

Globally about 106 million cases of chlamydia and 106 million cases of gonorrhea

occurred in 2008. The number of cases of PID; however, is not clear. This is largely
due to diagnostic tests being invasive and not included in routine check-ups, despite
PID being the most common reason for individuals to admit themselves under
gynecological care. It is estimated to affect about 1.5 percent of young women yearly.
In the United States PID is estimated to affect about one million people yearly. Rates
are highest with teenagers and first time mothers. PID causes over 100,000 women to
become infertile in the US each year.

Prevalence

Records show that...

18/10000 recorded discharges in the US after a diagnosis of PID.

Prevalence of self reported cases of PID for 18–44 was approximately 4.4%.

Findings that PID has an associated risk with previous STI diagnosis compared to
women with no previous STI diagnosis

1.1% of women, 16-46 years of age, in England and Wales are diagnosed with PID.

Despite the indications of a general decrease in PID rates, there is an observed rise

in the prevalence of gonorrhea and chlamydia. With that, in order to decrease the
prevalence of PID, one should test for gonorrhea and chlamydia.

Two nationally representative probability surveys referenced are the National

Health and Nutrition Examination Survey (NHANES) and the National Survey of
Family Growth (NSFG) surveyed women aged 18 to 44 from 2013 to 2014.

The results:

2.5 million women have had a PID diagnosis in the past.

The self-reported history decreased from 4.1% in 2013 to 3.6% in 2017.

It is possible that increased screening at annual gynecologist appointments has led to
an earlier detection and prevention of PID.

In white non-Hispanic women, the prevalence decreased from 4.9% to 3.9%, and in
Hispanic women, the prevalence decreased from 5.3% to 3.7%. In black non-Hispanic
women, the prevalence increased from 3.8% to 6.3%.


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

497

https://universalpublishings.com

The highest burden of PID recently is in black women and women living in the
Southern United States where there is a higher prevalence of STIs as well.

Disparities between races could be due to lower socioeconomic status. Those with a
lower income are less likely to get an annual gynecologist appointment or other
preventative measures and are more likely to be uninsured.


Population at risk.

Those who are sexually active with female (intact)reproductive organs and are under
the age of 25

Rarely observed in females who have had a hysterectomy

Overall age range 18-44

Those who have an STI that has gone untreated.

Women with more than one sexual partner

Inconsistent condom use for those not in a mutually monogamous relationship

Etiology of PID:

Untreated STI

multiple sexual partners

Sexually active under the age of 25

Usage of a douche

Causes damage to the bacteria that lives within the vagina

Slight increase risk when using an IUD not a massive increase in risk.

References

1.

^ Jump up to:

a

b

c

d

"Pelvic Inflammatory Disease (PID) Clinical Manifestations and

Sequelae". cdc.gov. October 2014. Archived from the original on February 22, 2015.
Retrieved February 21, 2015.

2.

^ Jump up to:

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o

p

q

r

s

Mitchell, C; Prabhu, M (December

2013). "Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and
treatment".
Infectious

Disease

Clinics

of

North

America. 27 (4): 793–

809. doi:10.1016/j.idc.2013.08.004. PMC 3843151. PMID 24275271.

3.

^ Jump up to:

a

b

Chang, A. H.; Parsonnet, J. (2010). "Role of Bacteria in

Oncogenesis". Clinical

Microbiology

Reviews. 23 (4): 837–

857. doi:10.1128/CMR.00012-10. ISSN 0893-8512. PMC 2952975. PMID 20930075.


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

498

https://universalpublishings.com

4.

^ Jump up to:

a

b

Chan, Philip J.; Seraj, Ibrahim M.; Kalugdan, Theresa H.; King, Alan

(1996). "Prevalence of Mycoplasma Conserved DNA in Malignant Ovarian Cancer
Detected Using Sensitive PCR–ELISA". Gynecologic Oncology. 63 (2): 258–
260. doi:
10.1006/gyno.1996.0316. ISSN 0090-8258. PMID 8910637.

5.

^ Jump up to:

a

b

c

d

Brunham RC, Gottlieb SL, Paavonen J (2015). "Pelvic

inflammatory disease". The New England Journal of Medicine. 372 (21): 2039–
48. doi:
10.1056/NEJMra1411426. PMID 25992748. S2CID 207846620.

6.

^ Jump up to:

a

b

"Pelvic Inflammatory Disease (PID) Patient Counseling and

Education". Centers for Disease Control. October 2014. Archived from the original on
February 22, 2015. Retrieved February 21, 2015.

7.

^ Jump up to:

a

b

c

"2010 STD Treatment Guidelines Pelvic Inflammatory Disease".

Centers for Disease Control. August 15, 2014. Archived from the original on February
22, 2015. Retrieved February 22, 2015.

8.

^ Jump

up

to:

a

b

c

d

e

Eschenbach,

D

(2008). "Acute

Pelvic

Inflammatory

Disease". Glob.

Libr.

Women's

Med. doi:10.3843/GLOWM.10029. ISSN 1756-

2228. S2CID 40912241.

9.

^

"Acute Pelvic Inflammatory Disease" (PDF). National Health Service. Archived

from the original (PDF) on 2023-01-24.

10.

^ Jump up to:

a

b

c

World Health Organization (2012). "Global incidence and

prevalence of selected curable sexually transmitted infections - 2008" (PDF). who.int.
pp. 2, 19. Archived
(PDF) from the original on March 19, 2015. Retrieved February
22, 2015.

11.

^ Jump up to:

a

b

c

"Pelvic Inflammatory Disease (PID) Partner Management and

Public Health Measures". Centers for Disease Control. October 2014. Archived
from the original
on February 22, 2015. Retrieved February 21, 2015.

12.

^ Jump up to:

a

b

"Self-Study STD Modules for Clinicians — Pelvic Inflammatory

Disease (PID) Next Centers for Disease Control and Prevention Your Online Source
for Credible Health Information CDC Home Footer Separator Rectangle
Epidemiology".
Centers for Disease Control. October 2014. Archived from the
original
on February 22, 2015. Retrieved February 21, 2015.

13.

^

Kumar, Ritu; Bronze, Michael Stuart (2015). "Pelvic Inflammatory Disease Empiric

Therapy". Medscape. Archived from the original on April 3, 2015. Retrieved March
30, 2015.


background image

МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:

ТЕОРИЯ И ПРАКТИКА

Researchbib Impact factor: 13.14/2024

SJIF 2024 = 5.444

Том 3, Выпуск 01, Январь

499

https://universalpublishings.com

14.

^

Zakher, Bernadette; Cantor MD, Amy G.; Daeges, Monica; Nelson MD, Heidi

(December 16, 2014). "Review: Screening for Gonorrhea and Chlamydia: A
Systematic Review for the U.S. Prevententive Services Task Force". Annals of Internal
Medicine. 161 (12): 884–894. CiteSeerX
10.1.1.691.6232. doi:10.7326/M14-
1022.
PMID 25244000. S2CID 207538182.

15.

^ Jump

up

to:

a

b

c

d

e

f

Ljubin-Sternak,

Suncanica;

Mestrovic,

Tomislav

(2014). "Review: Chlamydia trachonmatis and Genital Mycoplasmias: Pathogens with
an Impact on Human Reproductive Health".
Journal of Pathogens. 2014 (183167):
183167. doi:
10.1155/2014/183167. PMC 4295611. PMID 25614838.

16.

^

"Pelvic Inflammatory Disease - CDC Fact Sheet". www.cdc.gov. 2017-10-04.

Retrieved 2018-11-07.

17.

^

"Pelvic Inflammatory Disease". MedScape. March 27, 2014. Archived from the

original on March 13, 2015. Retrieved March 10, 2015.

18.

^

Planned Parenthood. "Pelvic Inflammatory Disease (PID)".

19.

^ Jump up to:

a

b

c

d

e

Sharma H, Tal R, Clark NA, Segars JH (2014). "Microbiota and

pelvic inflammatory disease". Seminars in Reproductive Medicine. 32 (1): 43–
9. doi:
10.1055/s-0033-1361822. PMC 4148456. PMID 24390920.

References

^ Jump up to:a b c d "Pelvic Inflammatory Disease (PID) Clinical Manifestations and Sequelae". cdc.gov. October 2014. Archived from the original on February 22, 2015. Retrieved February 21, 2015.

^ Jump up to:a b c d e f g h i j k l m n o p q r s Mitchell, C; Prabhu, M (December 2013). "Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment". Infectious Disease Clinics of North America. 27 (4): 793–809. doi:10.1016/j.idc.2013.08.004. PMC 3843151. PMID 24275271.

^ Jump up to:a b Chang, A. H.; Parsonnet, J. (2010). "Role of Bacteria in Oncogenesis". Clinical Microbiology Reviews. 23 (4): 837–857. doi:10.1128/CMR.00012-10. ISSN 0893-8512. PMC 2952975. PMID 20930075.

^ Jump up to:a b Chan, Philip J.; Seraj, Ibrahim M.; Kalugdan, Theresa H.; King, Alan (1996). "Prevalence of Mycoplasma Conserved DNA in Malignant Ovarian Cancer Detected Using Sensitive PCR–ELISA". Gynecologic Oncology. 63 (2): 258–260. doi:10.1006/gyno.1996.0316. ISSN 0090-8258. PMID 8910637.

^ Jump up to:a b c d Brunham RC, Gottlieb SL, Paavonen J (2015). "Pelvic inflammatory disease". The New England Journal of Medicine. 372 (21): 2039–48. doi:10.1056/NEJMra1411426. PMID 25992748. S2CID 207846620.

^ Jump up to:a b "Pelvic Inflammatory Disease (PID) Patient Counseling and Education". Centers for Disease Control. October 2014. Archived from the original on February 22, 2015. Retrieved February 21, 2015.

^ Jump up to:a b c "2010 STD Treatment Guidelines Pelvic Inflammatory Disease". Centers for Disease Control. August 15, 2014. Archived from the original on February 22, 2015. Retrieved February 22, 2015.

^ Jump up to:a b c d e Eschenbach, D (2008). "Acute Pelvic Inflammatory Disease". Glob. Libr. Women's Med. doi:10.3843/GLOWM.10029. ISSN 1756-2228. S2CID 40912241.

^ "Acute Pelvic Inflammatory Disease" (PDF). National Health Service. Archived from the original (PDF) on 2023-01-24.

^ Jump up to:a b c World Health Organization (2012). "Global incidence and prevalence of selected curable sexually transmitted infections - 2008" (PDF). who.int. pp. 2, 19. Archived (PDF) from the original on March 19, 2015. Retrieved February 22, 2015.

^ Jump up to:a b c "Pelvic Inflammatory Disease (PID) Partner Management and Public Health Measures". Centers for Disease Control. October 2014. Archived from the original on February 22, 2015. Retrieved February 21, 2015.

^ Jump up to:a b "Self-Study STD Modules for Clinicians — Pelvic Inflammatory Disease (PID) Next Centers for Disease Control and Prevention Your Online Source for Credible Health Information CDC Home Footer Separator Rectangle Epidemiology". Centers for Disease Control. October 2014. Archived from the original on February 22, 2015. Retrieved February 21, 2015.

^ Kumar, Ritu; Bronze, Michael Stuart (2015). "Pelvic Inflammatory Disease Empiric Therapy". Medscape. Archived from the original on April 3, 2015. Retrieved March 30, 2015.

^ Zakher, Bernadette; Cantor MD, Amy G.; Daeges, Monica; Nelson MD, Heidi (December 16, 2014). "Review: Screening for Gonorrhea and Chlamydia: A Systematic Review for the U.S. Prevententive Services Task Force". Annals of Internal Medicine. 161 (12): 884–894. CiteSeerX 10.1.1.691.6232. doi:10.7326/M14-1022. PMID 25244000. S2CID 207538182.

^ Jump up to:a b c d e f Ljubin-Sternak, Suncanica; Mestrovic, Tomislav (2014). "Review: Chlamydia trachonmatis and Genital Mycoplasmias: Pathogens with an Impact on Human Reproductive Health". Journal of Pathogens. 2014 (183167): 183167. doi:10.1155/2014/183167. PMC 4295611. PMID 25614838.

^ "Pelvic Inflammatory Disease - CDC Fact Sheet". www.cdc.gov. 2017-10-04. Retrieved 2018-11-07.

^ "Pelvic Inflammatory Disease". MedScape. March 27, 2014. Archived from the original on March 13, 2015. Retrieved March 10, 2015.

^ Planned Parenthood. "Pelvic Inflammatory Disease (PID)".

^ Jump up to:a b c d e Sharma H, Tal R, Clark NA, Segars JH (2014). "Microbiota and pelvic inflammatory disease". Seminars in Reproductive Medicine. 32 (1): 43–9. doi:10.1055/s-0033-1361822. PMC 4148456. PMID 24390920.